Skip to content
The BMJ
  • Latest
  • Authors
    • Columnists
    • Guest writers
    • Editors at large
    • A to Z
  • Topics
    • NHS
    • US healthcare
    • South Asia
    • China
    • Patient and public perspectives
    • More …

Access thebmj.com - The BMJ logo

Richard Lehman’s weekly review of medical journals

Richard Lehman’s journal review—24 November 2014

November 24, 2014

NEJM 20 November 2014 Vol 371 1963 The melanoma trials last week got me thinking about how the current model of cancer drug research lets down trial participants and dying […]

More…

Richard Lehman's weekly review of medical journals2 Comments

Richard Lehman’s journal review—17 November 2014

November 17, 2014

NEJM 13 November 2014 Vol 371 1867 “Metastatic melanoma remains just over the border of curability. As we wait and hope for some breakthrough in an agonizingly incremental process, there […]

More…

Richard Lehman's weekly review of medical journals1 Comment

Richard Lehman’s journal review—10 November 2014

November 10, 2014

NEJM 6 November 2014 Vol 371 1771 The first paper in the New England Journal this week describes a French trial of rituximab versus azathioprine for maintenance in ANCA associated […]

More…

Richard Lehman's weekly review of medical journals1 Comment

Richard Lehman’s journal review—3 November 2014

November 3, 2014

NEJM 30 October 2014 Vol 371 1685 The treatment of childhood and adolescent cancer is territory that most of us don’t trespass on, but we’ll need to go there this week […]

More…

Richard Lehman's weekly review of medical journals1 Comment

Richard Lehman’s journal review—27 October 2014

October 27, 2014

NEJM 22 October 2014 Vol 371 1577 The whole point about tuberculosis is that it is slow. The discoverer of its causative organism, Robert Koch, called it the fungus-germ, or […]

More…

Richard Lehman's weekly review of medical journals0 Comments

Richard Lehman’s journal review—20 October 2014

October 20, 2014

NEJM 16 October 2014 Vol 371 1507  I hate military metaphors for cancer as much as anybody, but here is a study which describes hell in the leukaemia trenches. The […]

More…

Richard Lehman's weekly review of medical journals0 Comments

Richard Lehman’s journal review—13 October 2014

October 13, 2014

NEJM 9 October 2014 Vol 371 1381  With blood transfusion, it seems that less is usually better. This has been shown in renal patients and palliative care, and is now […]

More…

Richard Lehman's weekly review of medical journals0 Comments

Richard Lehman’s journal review—6 October 2014

October 6, 2014

NEJM 2 October 2014 Vol 371 1285  Here is a trial which had me taking my glasses off and scratching my bald patch. Why on earth should a drug company—in this […]

More…

Richard Lehman's weekly review of medical journals, South Asia0 Comments

Richard Lehman’s journal review—29 September 2014

September 29, 2014

NEJM 25 September 2014 Vol 371 1189  This week we start with mepolizumab. Before we know it, we encounter losmapimod. Enough is enough. I think the World Health Organization should […]

More…

Richard Lehman's weekly review of medical journals, South Asia0 Comments

Richard Lehman’s journal review—22 September 2014

September 22, 2014

NEJM 18 September 2014 Vol 371 1100  The way I have ureteric colic is so classical that just watching me sweat and groan is enough for anyone to make the […]

More…

Richard Lehman's weekly review of medical journals, South Asia1 Comment
  • «Previous page
  • 18
  • 19
  • 20
  • 21
  • 22
  • »Next page
  • 69

Comment and opinion from The BMJ's international community of readers, authors, and editors

Access bmj.com
The BMJ logo

Most Read

  • Elizabeth Romer: Changing the way we talk about…
  • Paul Garner: on his recovery from long covid
  • Up the line to death: covid-19 has revealed a mortal…

Categories

  • Author's perspective
  • BMJ Clinical Evidence
  • Brexit
  • China
  • Christmas appeal
  • Climate change
  • Columnists
    • Abraar Karan
    • Andy Cowper
    • Billy Boland
    • Charlotte Squires
    • Chris Ham
    • Daniel Sokol
    • David Kerr
    • David Lock
    • David Oliver
    • Desmond O'Neill
    • Douglas Noble
    • Edzard Ernst
    • From the other side
    • Gerd Gigerenzer
    • Giles Maskell
    • Harlan Krumholz
    • Hilda Bastian
    • Iain Chalmers
    • James Raftery's NICE blogs
    • Jeff Aronson's Words
    • Jim Murray
    • Julian Sheather
    • Julie K Silver
    • Kieran Walsh
    • Liz Wager
    • Margaret McCartney
    • Marge Berer
    • Martin McKee
    • Martin McShane
    • Mary E Black
    • Mary Higgins
    • Matt Morgan
    • Metaphor watch
    • Muir Gray
    • Neal Maskrey
    • Neena Modi
    • Nick Hopkinson
    • Paul Glasziou
    • Penny Campling
    • Peter Brindley
    • Pritpal S Tamber
    • Rachel Clarke
    • Richard Lehman
    • Richard Smith
    • Sandra Lako
    • Sharon Roman
    • Sian Griffiths
    • Siddhartha Yadav
    • Simon Chapman
    • Tara Lamont
    • Tiago Villanueva
    • Tom Jefferson
    • Tracey Koehlmoos
    • William Cayley
  • Covid-19 known unknowns webinars
  • Editors at large
    • Anita Jain
    • Anya de Iongh
    • Birte Twisselmann
    • Carl Heneghan
    • David Payne
    • Domhnall MacAuley
    • Elizabeth Loder
    • Fiona Godlee
    • Georg Röggla
    • Juliet Dobson
    • Paul Simpson
    • Peter Doshi
    • Readers' editor
    • Robin Baddeley
    • Sally Carter
    • Tessa Richards
    • The BMJ today
  • Featured
  • From the archive
  • Global health
    • Global health disruptors
  • Guest writers
    • The King's fund
  • Junior doctors
  • Literature and medicine
  • Medical ethics
  • MSF
  • NHS
  • Open data
  • Partnership in practice
  • Patient and public perspectives
  • People's covid inquiry
  • Richard Lehman's weekly review of medical journals
  • South Asia
  • Students
  • Too much medicine
  • Uncategorized
  • Unreported trial of the week
  • US healthcare
  • Weekly review of medical journals
  • Wellbeing

BMJ CAREERS

Information for Authors

BMJ Opinion provides comment and opinion written by The BMJ's international community of readers, authors, and editors.

We welcome submissions for consideration. Your article should be clear, compelling, and appeal to our international readership of doctors and other health professionals. The best pieces make a single topical point. They are well argued with new insights.

For more information on how to submit, please see our instructions for authors.

  • Contact us
  • Website terms & conditions
  • Privacy policy
  • Revenue sources
  • Home
  • Top

© BMJ Publishing Group Limited 2025. All rights reserved.